Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Niaspan Side Effects May Increase Stroke Risk: Study November 17, 2011 Staff Writers Add Your Comments The results of an aborted study on the cholesterol drug Niaspan suggest that the Abbott Laboratories medication may increase the risk of a stroke. Earlier this week, the National Heart, Lung and Blood Institute (NHLBI) released the final data from its AIM-HIGH clinical trial, which was halted 18 months early in May. The study was stopped due to concerns about an increased risk of stroke from side effects of Niaspan and because the drug showed no signs of lowering LDL cholesterol levels, often referred to as “bad” cholesterol. Do You Know about… SPORTS BETTING ADDICTION LAWSUITs Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITs Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The clinical trial involved 3,414 patients given either Niaspan or a placebo. While there were significant increases in HDL cholesterol (“good” cholesterol) and lowered triglyceride levels, there was no clinical benefit on LDL levels or in people suffering from atherosclerotic cardiovascular disease, which is caused by high levels of LDL cholesterol. Additionally, 27 patients given Niaspan suffered an ischemic stroke, compared to only 15 patients given a placebo. The results of the study, and its cancellation, sparked controversy among researchers, some of whom say the clinical trial should have continued and believe that the rate of strokes may have be due to chance and are statistically insignificant. The subjects of the trial also had levels of bad cholesterol that were already under control. Niaspan (niacin) was approved by the FDA in 2005, but is an extended release version of a cholesterol drug that was first approved in 1957. Niacin is also available in generic form. However, following the AIM-HIGH trial results, some researchers say the drug may not have much of a future. Another, larger, clinical trial known as HPS2-THRIVE is currently underway. Some experts suggest that if THRIVE also shows a lack of efficacy or increased stroke risk then doctors should consider taking patients off the drug. Until then, most experts think that patients should not stop taking Niaspan. THRIVE will involve 24,000 participants with more varying cholesterol levels. Tags: Abbott, Cholesterol, Cholesterol Drug, Niaspan, Stroke Image Credit: | More Lawsuit Stories Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks March 9, 2026 As Paraquat Parkinson’s Disease Cases Continue To Emerge, Syngenta Will Halt Herbicide’s Production March 9, 2026 Rhode Island Catholic Church Covered Up Sexual Abuse of Children For Decades: Report March 9, 2026 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks (Posted: yesterday) A Georgia couple’s lawsuit claims the makers of Dupixent failed to provide adequate warnings about the risk of mycosis fungoides, a type of T-cell lymphoma. MORE ABOUT: DUPIXENT LAWSUITDupixent Caused T-Cell Lymphoma or Rapidly Progressed Cancer, Lawsuit Alleges (02/25/2026)MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (02/19/2026)Lawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026) Port Catheter Lawyers Outline Process for Selecting Bellwether Lawsuits in AngioDynamics MDL (Posted: 4 days ago) In a joint statement, plaintiffs and defendants in AngioDynamics port catheter lawsuits have laid guidelines for what types of cases should be selected to serve as potential bellwether trials. MORE ABOUT: ANGIODYNAMICS PORT CATHETER LAWSUITPort Catheter Blood Clot Results in Lawsuit Against Device Manufacturer (02/04/2026)SmartPort Infection Lawsuit Alleges AngioDynamics Catheter Defects Forced Surgical Removal (01/30/2026)Severe Sepsis Infection Leads to Vortex Port Catheter Wrongful Death Lawsuit (01/12/2026) Breast Mesh Implant Complications Often Leave Women Asking If They Have a Lawsuit (Posted: 5 days ago) Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation. MORE ABOUT: BREAST MESH LAWSUITCosmetic Surgeons Warn Against Using Internal Bra Mesh for Breast Lifts (12/11/2025)GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (11/14/2025)Breast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)
Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks March 9, 2026
As Paraquat Parkinson’s Disease Cases Continue To Emerge, Syngenta Will Halt Herbicide’s Production March 9, 2026
Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks (Posted: yesterday) A Georgia couple’s lawsuit claims the makers of Dupixent failed to provide adequate warnings about the risk of mycosis fungoides, a type of T-cell lymphoma. MORE ABOUT: DUPIXENT LAWSUITDupixent Caused T-Cell Lymphoma or Rapidly Progressed Cancer, Lawsuit Alleges (02/25/2026)MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide (02/19/2026)Lawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL (02/10/2026)
Port Catheter Lawyers Outline Process for Selecting Bellwether Lawsuits in AngioDynamics MDL (Posted: 4 days ago) In a joint statement, plaintiffs and defendants in AngioDynamics port catheter lawsuits have laid guidelines for what types of cases should be selected to serve as potential bellwether trials. MORE ABOUT: ANGIODYNAMICS PORT CATHETER LAWSUITPort Catheter Blood Clot Results in Lawsuit Against Device Manufacturer (02/04/2026)SmartPort Infection Lawsuit Alleges AngioDynamics Catheter Defects Forced Surgical Removal (01/30/2026)Severe Sepsis Infection Leads to Vortex Port Catheter Wrongful Death Lawsuit (01/12/2026)
Breast Mesh Implant Complications Often Leave Women Asking If They Have a Lawsuit (Posted: 5 days ago) Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation. MORE ABOUT: BREAST MESH LAWSUITCosmetic Surgeons Warn Against Using Internal Bra Mesh for Breast Lifts (12/11/2025)GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (11/14/2025)Breast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)